[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100094359":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":54,"collaborators":10,"id":56,"slug":10,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":10,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational (electronic health record review)",null,"Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.",[13,14],"Procedure: Biospecimen Collection","Other: Electronic Health Record Review",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"PROCEDURE","Biospecimen Collection","Patients' residual tissue samples are collected",[9],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Electronic Health Record Review","Medical records are reviewed",[9],[26],{"name":27,"affiliation":5,"role":28},"David M Gershenson","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Lisa Nathan","CONTACT","713-745-3837","lcnathan@mdanderson.org",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"M D Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States",{"type":44,"coordinates":45},"Point",[46,47],-95.36327,29.76328,{"lat":47,"lon":46},[50,53],{"name":51,"role":32,"phone":52,"phoneExt":10,"email":10},"David M. Gershenson","713-563-4535",{"name":51,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100094359",false,"NCT00488878","Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors","Data Collection for Patients With Low Grade Ovarian Carcinoma","Inclusion Criteria:\n\n* Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:\n\n  * Ovarian tumor of low malignant potential\n  * Low-grade serous carcinoma of the ovary\n  * Primary peritoneal tumor of low malignant potential\n  * Low-grade serous carcinoma of the peritoneum\n  * Psammocarcinoma","FEMALE",{"count":64,"type":65},2000,"ESTIMATED","OBSERVATIONAL","This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.",[69,70,71,72,73,74],"Low Grade Ovarian Serous Adenocarcinoma","Malignant Ovarian Neoplasm","Ovarian Carcinoma","Primary Peritoneal Carcinoma","Primary Peritoneal Low Grade Serous Adenocarcinoma","Psammocarcinoma","2026-02-11",{"date":77,"type":78},"2026-02-13","ACTUAL",{"date":80,"type":78},"2006-05-19",{"date":82,"type":65},"2035-05-01",{"name":5,"class":6},1]